Navigation Links
Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
Date:6/22/2009

ll molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Forward Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements related to future clinical development plans for Stimuvax. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events and circumstances.

Forward-looking statements involve risks and uncertainties, including risks and uncertainties related to Oncothyreon's business and the general economic environment. Many of these risks and uncertainties are beyond Oncothyreon's control. These risks, uncertainties and other factors could cause our actual results to differ materially from those projected in forward-looking statements. Risks, uncertainties, and assumptions include those predicting the timing, duration and results of clinical trials, the timing and results of regulatory reviews, the safety and efficacy of Stimuvax, the indications for which Stimuvax might be developed, and Merck Serono's development plans for Stimuvax. There can be no guarantee that the results of preclinical studies or clinical trials will be predictive of either safety or efficacy in future clinical trials. These and other risks and uncertainties are described in the reports and other documents filed by Oncothyreon Inc. with the SEC and/or Canadian regulatory authorities.

Although Oncothyreon believes that any forward-looking statements contained herein are reasonable, it can give no assurance that its expectations are correct. All forward-looking
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
2. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Oncothyreon announces closing of $11.1 million registered direct financing
4. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
5. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
6. Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Oncothyreon reports first quarter 2009 financial results
8. Oncothyreon regains compliance with NASDAQ listing requirements
9. Oncothyreon to present at Invest Northwest 2009
10. Oncothyreon reports full year and fourth quarter 2008 financial results
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Elsevier , a world-leading provider of ... announced the highlights of its journal Impact Factor performance ... (JCR) published by Thomson Reuters, Elsevier saw 55% of ... ahead of the aggregate across other journals. In 2014, ... categories, up from 61 in 2013. An ...
(Date:6/26/2015)... , June 26, 2015   ... ), a pet therapeutics company focused on ... biopharmaceutical products for companion animals, today announced ... study of capromorelin (AT-002), the company,s innovative ... is a small molecule that mimics ghrelin, ...
(Date:6/26/2015)... ... June 26, 2015 , ... Charm Sciences, Inc. ... Packers and Stockyards Administration (GIPSA) awarded a five year contract to Charm Sciences ... utilizing Charm’s ROSA DONQ-FAST5 Test. This 5 minute quantitative test extracts DON from ...
(Date:6/26/2015)... NEW YORK and MUMBAI, India ... (TCS), (BSE: 532540, NSE: TCS) a leading global IT ... has been designated as a Leader in Worldwide Life ... IDC, in the " IDC MarketScape: Worldwide Life Science ... 2015) report. The report evaluated eight ...
Breaking Biology Technology:Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4
... Nov. 12, 2010 Ardea Biosciences, Inc. (Nasdaq: ... and chief executive officer, will present at the following upcoming ... Healthcare Conference in New York, NY. Presentation: 1:40 p.m. EST on ... Annual Health Care Conference in New York, NY. Presentation: 1:00 ...
... from Thomson Reuters released today shows that the US is no ... kept pace with the increased output from European and Asia-Pacific nations. ... found that research output from the US has been surpassed by ... 40 percent of research papers in the most influential journals(1). By ...
... Cat fanciers everywhere appreciate the gravity-defying grace and exquisite balance ... extend even to the way cats lap milk? Researchers ... domestic and big cats lap and found that felines of ... physical forces. The results will be published in the ...
Cached Biology Technology:Ardea Biosciences to Present at Two Upcoming Investor Conferences 2Ardea Biosciences to Present at Two Upcoming Investor Conferences 3US Dominance in Scientific Research Significantly Challenged by Increased Competition from Europe and Asia, According to Thomson Reuters Study 2Cats show perfect balance even in their lapping 2Cats show perfect balance even in their lapping 3Cats show perfect balance even in their lapping 4
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... challenges Africa faces when it comes to feeding its ... and famine let alone broader food security issues ... these challenges in the longer term is equally important, ... and development. A re-invigorated effort to boost African ...
... Protection Agency issued its first comprehensive report on major ... list, accounting for more than 70 percent of industrial ... Many climate experts have urged power plants and other ... atmosphere and sequester it deep underground a technique ...
... Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ... protein (CETP) mediates the transfer of cholesterol from "good" ... (LDLs). These findings point the way to the design ... could help prevent the development of heart disease. ...
Cached Biology News:Cutting-edge science creating solutions for African agriculture 2Stanford scientist to discuss the challenges and opportunities of carbon sequestration at AAAS 2How good cholesterol turns bad 2How good cholesterol turns bad 3
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
... Virgin, optically clear polystyrene with frosted ... coordinates for cell counting. 100% integrity ... a new product number, created to ... showing no availability yet, please order ...
... LIC Duet™ T7•Tag ® Ek Adaptor ... operator, ribosome binding site (rbs), ATG translation ... sequence. The T7•Tag is a small epitope ... detection of the target protein with T7•Tag ...
The LIC Duet™ Mini Adaptor encodes a T7 promoter, lac operator, ribosome binding site (rbs), and an ATG translation initation codon. This adaptor is designed for expression of a target protei...
Biology Products: